Commentary on "Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease"

Alzheimers Dement. 2006 Jul;2(3):140-2. doi: 10.1016/j.jalz.2006.03.017.
No abstract available

Publication types

  • Comment